• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性家族性肝内胆汁淤积症(比勒病[PFIC - 1]和比勒综合征)的遗传学及形态学研究结果:异质性证据

Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity.

作者信息

Bull L N, Carlton V E, Stricker N L, Baharloo S, DeYoung J A, Freimer N B, Magid M S, Kahn E, Markowitz J, DiCarlo F J, McLoughlin L, Boyle J T, Dahms B B, Faught P R, Fitzgerald J F, Piccoli D A, Witzleben C L, O'Connell N C, Setchell K D, Agostini R M, Kocoshis S A, Reyes J, Knisely A S

机构信息

Department of Psychiatry, University of California San Francisco, USA.

出版信息

Hepatology. 1997 Jul;26(1):155-64. doi: 10.1002/hep.510260121.

DOI:10.1002/hep.510260121
PMID:9214465
Abstract

Byler disease (ByD) is an autosomal recessive disorder in which cholestasis of onset in infancy leads to hepatic fibrosis and death. Children who have a clinically similar disorder, but are not members of the Amish kindred in which ByD was described, are said to have Byler syndrome (ByS). Controversy exists as to whether ByD and ByS (subtypes of progressive familial intrahepatic cholestasis [PFIC]) represent one clinicopathological entity. The gene for ByD has been mapped to a 19-cM region of 18q21-q22. PFIC caused by a lesion in this region, including ByD, can be designated PFIC-1. Examination of haplotypes in siblings with ByS in two unrelated non-Amish families showed that the gene(s) responsible for their disorder(s) did not lie in the PFIC-1 candidate region. On light microscopy and transmission electron microscopy (TEM), liver tissue differed between Amish children with PFIC-1, who had coarsely granular bile and at presentation had bland intracanalicular cholestasis, and the children with ByS in the two non-Amish families, who had amorphous or finely filamentous bile and at presentation had neonatal hepatitis. Bile acid composition of bile also differed: In the Amish children with PFIC-1 and in one ByS family, the proportional concentration of chenodeoxycholic acid (CDCA) in bile was low compared with normal bile; in the other ByS family, it was only slightly reduced. Genetic analysis and light microscopy and TEM of liver may help distinguish PFIC-1 from other forms of ByS.

摘要

拜勒病(ByD)是一种常染色体隐性疾病,婴儿期发病的胆汁淤积会导致肝纤维化并最终死亡。患有临床症状相似疾病,但并非最初描述拜勒病的阿米什家族成员的儿童,被称为患有拜勒综合征(ByS)。拜勒病和拜勒综合征(进行性家族性肝内胆汁淤积症[PFIC]的亚型)是否代表同一临床病理实体存在争议。拜勒病的基因已被定位到18q21 - q22的一个19厘摩区域。由该区域病变导致的PFIC,包括拜勒病,可被命名为PFIC - 1。对两个不相关的非阿米什家族中患有拜勒综合征的兄弟姐妹的单倍型进行检测发现,导致他们疾病的基因并不位于PFIC - 1候选区域。在光学显微镜和透射电子显微镜(TEM)下观察,患有PFIC - 1的阿米什儿童的肝组织与两个非阿米什家族中患有拜勒综合征的儿童的肝组织不同,前者胆汁呈粗大颗粒状,初发时表现为管腔内胆汁淤积,后者胆汁呈无定形或细丝状,初发时表现为新生儿肝炎。胆汁的胆汁酸组成也有所不同:在患有PFIC - 1的阿米什儿童和一个拜勒综合征家族中,胆汁中鹅去氧胆酸(CDCA)的比例浓度低于正常胆汁;在另一个拜勒综合征家族中,其仅略有降低。基因分析以及肝脏的光学显微镜和透射电子显微镜检查可能有助于区分PFIC - 1和其他形式的拜勒综合征。

相似文献

1
Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity.进行性家族性肝内胆汁淤积症(比勒病[PFIC - 1]和比勒综合征)的遗传学及形态学研究结果:异质性证据
Hepatology. 1997 Jul;26(1):155-64. doi: 10.1002/hep.510260121.
2
Progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症
Acta Biomed. 2002;73(3-4):53-6.
3
Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region.将进行性家族性肝内胆汁淤积症(拜勒病)的一个基因座定位到18q21 - q22,即良性复发性肝内胆汁淤积症区域。
Hum Mol Genet. 1995 Jun;4(6):1049-53. doi: 10.1093/hmg/4.6.1049.
4
[Progressive familial intrahepatic cholestasis and hereditary anomalies lf hepatocellular metabolism of bile acids].[进行性家族性肝内胆汁淤积症与肝细胞胆汁酸代谢的遗传性异常]
Arch Pediatr. 1998 Jan;5(1):45-53. doi: 10.1016/s0929-693x(97)83467-7.
5
Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.针对进行性家族性肝内胆汁淤积症的胆汁转流术:改善肝脏形态及胆汁酸谱。
Gastroenterology. 2003 Oct;125(4):1227-34. doi: 10.1016/s0016-5085(03)01199-5.
6
Byler-like familial cholestasis in an extended kindred.一个大家族中的Byler样家族性胆汁淤积症。
Arch Dis Child. 1996 Sep;75(3):223-7. doi: 10.1136/adc.75.3.223.
7
Progressive familial intrahepatic cholestasis: a personal perspective.进行性家族性肝内胆汁淤积症:个人观点。
Pediatr Dev Pathol. 2000 Mar-Apr;3(2):113-25. doi: 10.1007/s100240050016.
8
PFIC type III in infant presenting as acute liver cell failure.表现为急性肝衰竭的婴儿III型进行性家族性肝内胆汁淤积症
Indian J Pathol Microbiol. 2010 Apr-Jun;53(2):334-6. doi: 10.4103/0377-4929.64326.
9
Locus heterogeneity in progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症中的基因座异质性
J Med Genet. 1996 Oct;33(10):833-6. doi: 10.1136/jmg.33.10.833.
10
[Progressive familial intrahepatic cholestasis (Byler disease): current genetics and therapy].[进行性家族性肝内胆汁淤积症(比勒病):当前的遗传学与治疗]
Klin Padiatr. 2000 Mar-Apr;212(2):64-70. doi: 10.1055/s-2000-9654.

引用本文的文献

1
ATP8B1 regulates PIP2 localization and cleavage of pyroptotic executioner Gasdermin D.ATP8B1调节磷脂酰肌醇-4,5-二磷酸(PIP2)的定位以及焦亡执行者Gasdermin D的切割。
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2502798122. doi: 10.1073/pnas.2502798122. Epub 2025 May 29.
2
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.用于治疗胆汁淤积性肝病的过氧化物酶体增殖物激活受体激动剂:十年多的临床进展
Hepatol Commun. 2024 Dec 20;9(1). doi: 10.1097/HC9.0000000000000612. eCollection 2025 Jan 1.
3
Long-Term Outcome after Liver Transplantation for Progressive Familial Intrahepatic Cholestasis.
进展性家族性肝内胆汁淤积症行肝移植的长期预后。
Medicina (Kaunas). 2021 Aug 22;57(8):854. doi: 10.3390/medicina57080854.
4
Congenital Diarrhea and Cholestatic Liver Disease: Phenotypic Spectrum Associated with MYO5B Mutations.先天性腹泻和胆汁淤积性肝病:与MYO5B突变相关的表型谱
J Clin Med. 2021 Jan 28;10(3):481. doi: 10.3390/jcm10030481.
5
Biopsy Validated Study of Biomarkers for Liver Fibrosis and Transplant Prediction in Inherited Cholestasis.遗传性胆汁淤积症中肝纤维化生物标志物及移植预测的活检验证研究
Hepatol Commun. 2020 Aug 1;4(10):1516-1526. doi: 10.1002/hep4.1569. eCollection 2020 Oct.
6
Comorbidity between progressive familial intrahepatic cholestasis and atopic dermatitis in a 19-month-old child.一名19个月大儿童的进行性家族性肝内胆汁淤积症与特应性皮炎的共病情况。
BMJ Case Rep. 2019 Oct 18;12(10):e230152. doi: 10.1136/bcr-2019-230152.
7
Expanding etiology of progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症病因的扩展
World J Hepatol. 2019 May 27;11(5):450-463. doi: 10.4254/wjh.v11.i5.450.
8
Progressive Familial Intrahepatic Cholestasis in Korea: A Clinicopathological Study of Five Patients.韩国的进行性家族性肝内胆汁淤积症:5例患者的临床病理研究
J Pathol Transl Med. 2019 Jul;53(4):253-260. doi: 10.4132/jptm.2019.05.03. Epub 2019 May 16.
9
Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment.进行性家族性肝内胆汁淤积症:诊断、管理与治疗
Hepat Med. 2018 Sep 10;10:95-104. doi: 10.2147/HMER.S137209. eCollection 2018.
10
New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.遗传胆汁淤积症的新见解:从分子机制到临床意义。
Can J Gastroenterol Hepatol. 2018 Jul 26;2018:2313675. doi: 10.1155/2018/2313675. eCollection 2018.